Histopathological Diagnosis amongst Subjects of Liver Diseases Reporting to the Pathology Department: An Institutional Based Study

  • Kamlesh Yadav Associate Professor, Department of Pathology, SMS Medical College & Hospital, Jaipur, Rajasthan, India.
  • Mukesh Kumar Khinchi Associate Professor, Department of Pathology, SMS Medical College & Hospital, Jaipur, Rajasthan, India.
Keywords: Hepatic, Inflammation, Mesenchymal.


Background: Chronic liver diseases are one of the greatest cause deaths around the world, representing around 1.03 million deaths each year. The aim of the present study was to evaluate the histopathological diagnosis of subjects with liver disease.

Materials and methods: The present study was conducted in a prospective fashion enrolling 120 subjects reporting to the Department of Pathology, SMS Medical College & Hospital, Jaipur, Rajasthan (India) with liver disorders. There were 60 cases of hepatitis either viral or non-viral and 60 cases of cirrhosis of mixed etiology. All the data thus obtained was arranged in a tabulated form and analyzed using SPSS software. Percentage and frequency distribution were used to describe the results.

Results: The present study enrolled 120 subjects, out of these 80 were males and 40 were females. The mean age of the study population was 40.23+/- 7.89 years. Ductopenia was shown by single subject of liver cirrhosis. Blood stasis was observed by 3.3% liver cirrhosis and 1.7% hepatitis subjects. Focal type of necrosis was seen amongst 68.3% (n=41) liver cirrhosis subjects and 73.3% (n=44) hepatitis subjects. Inflammatory infiltrate was seen amongst 36.7% (n=22) liver cirrhosis subjects and 16.7% (n=10) chronic hepatitis subjects.

Conclusion: In present study; portal inflammation was most common mesenchymal change in liver cirrhosis and hepatitis. Focal type of necrosis was seen in both the cases.




Download data is not yet available.

Author Biography

Mukesh Kumar Khinchi, Associate Professor, Department of Pathology, SMS Medical College & Hospital, Jaipur, Rajasthan, India.




1. Saxena R, Zucker SD, Crawford JM. Anatomy and physiology of the liver. In: Zakim D, Boyer TD (eds). Hepatology: a textbook of liver disease. 4 th edition, Saunders, Philadelphia, 2003, 3–30.
2. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Sacco RL, Salomon JA, Sampson U, Sanman E, Schwebel DC. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 2012, 380(9859):2095–0128.
3. Fernández-Iglesias A, Gracia-Sancho J. How to face chronic liver disease: the sinusoidal perspective. Front Med (Lausanne), 2017, 4:7.
4. Aizawa Y, Hokari A. Autoimmune hepatitis: current challenges and future prospects. Clin Exp Gastroenterol, 2017, 10:9–18.
5. Sookoian S, Pirola CJ. Systems biology elucidates common pathogenic mechanisms between nonalcoholic and alcoholic- fatty liver disease. PLoS One, 2013, 8:e58895.
6. Shah VS. Alcoholic Liver Disease. In: Hauser S, editors. Mayo Clinic Gastroenterology and Hepatology Broad Review. 4 th ed. New York: Oxford University Press; 2011.p 295-303.
7. Bal MS, Singh SP, Bodal VK, Oberoi SS, Surinder K. Pathological findings in liver autopsy. Journal of Indian Academy of Forensic Medicine 2004; 26(2):971-73.
8. Sotoudehamanesh R, Sotoudeh M, Asgari A, Abedi-Ardakani B, Tavangar SM, Khakinejad A et al. Silent Liver Diseases in Autopsies from Forensic Medicine of Tehran. Archives of Iranian Medicine 2006 Oct; 9(4):324-28.
9. Ghosh CK, Islam F, Ahmed E, Ghosh DK, Haque A, Islam QT et al. Etiological and Clinical Patterns of Isolated Hepatomegaly at Rajshahi, Bangladesh. Euroasian Journal of Hepato- Gastroenterology.2012 Jan-June;2(1):1-4.
10. Kringsholm B, Christoffersen P. Liver pathology in fatal drug addiction. Forensic Science International 1982 Sep-Oct; 20(2): 141-51.
11. Passarino G, Ciccone G, Siragusa R, Tappero P, Mollo F. Histopathological Findings in 851 Autopsies, with Toxicological and Virological Correlations. American Journal of Forensic Medicine and Pathology 2005 June; 26(2):106-16.
12. Daina CM, Daina LG, Bonta M, Rahotă DA, MuŢiu GA. Study concerning the histopathological changes in chronic hepatopathies. Romanian journal of morphology and embryology= Revue roumaine de morphologie et embryologie. 2017 Jan 1;58(1):153-9.
13. Craig CE, Quaglia A, Selden C, Lowdell M, Hodgson H, Dhillon AP. The histopathology of regeneration in massive hepatic necrosis. Semin Liver Dis, 2004, 24(1):49–64.
14. Łapiński TW, Panasiuk A, Flisiak R, Wierzbicka I. Liver biopsy: the mandatory test in liver diagnosis in adults. Pol Merkur Lekarski, 2001, 11(63):214–217.
15. Walsh MJ, Vanags DM, Clouston AD, Richardson MM, Purdie DM, Jonsson JR, Powell EE. Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury. Hepatology, 2004, 39(5):1230–1238.
16. Friedman SL. Hepatic fibrosis: emerging therapies. Dig Dis, 2015, 33(4):504–507.
17. Lee YA, Wallace MC, Friedman SL. Pathobiology of liver fibrosis: a translational success story. Gut, 2015, 64(5):830–41.
18. Natarajan V, Harris EN, Kidambi S. SECs (sinusoidal endothelial cells), liver microenvironment, and fibrosis. Biomed Res Int, 2017:4097205.
19. Petrescu IO, Biciuşcă V, Taisescu CI, Alexandru DO, Taisescu O, Comănescu MV, Petrescu F, Popescu IA, Traşcă DM, Forţofoiu MC, Siloşi CA, Forţofoiu M. Histological factors that predict the liver fibrosis in patients with chronic hepatitis C. Rom J Morphol Embryol, 2016, 57(2 Suppl):759–765.
20. Efrem IC, Istrătoaie O, Micu ES, Gheonea C, Lazăr DŞ, Firulescu SC, Predescu OI, Popescu NL. Anatomo-clinical correlations in hepatic steatosis in patients with C chronic hepatitis. Rom J Morphol Embryol, 2016, 57(2):513–519.
21. Ionică FE, Mogoantă L, Nicola GC, Chiriţă C, Negreş S, Bejenaru C, Turculeanu A, Badea O, Popescu NL, Bejenaru LE. Antifibrotic action of telmisartan in experimental carbon tetra-chloride-induced liver fibrosis in Wistar rats. Rom J Morphol Embryol, 2016, 57(4):1261–72.
22. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest, 2005, 115(2):209–218.
23. Jung YK, Yim HJ. Reversal of liver cirrhosis: current evidence and expectations. Korean J Intern Med, 2017, 32(2):213–228.
24. Ueno T, Sata M, Sakata R, Torimura T, Sakamoto M, Sugawara H, Tanikawa K. Hepatic stellate cells and intralobular innervation in human liver cirrhosis. Hum Pathol, 1997, 28(8): 953–59.
25. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology, 2008, 134(6):1655–1669.
26. Pinzani M. Pathophysiology of liver fibrosis. Dig Dis, 2015, 33(4):492–497.
27. Tacke F, Trautwein C. Mechanisms of liver fibrosis resolution. J Hepatol, 2015, 63(4):1038–1039.
How to Cite
Yadav K, Khinchi MK. Histopathological Diagnosis amongst Subjects of Liver Diseases Reporting to the Pathology Department: An Institutional Based Study. Int Arch BioMed Clin Res [Internet]. 2020Jun.29 [cited 2020Jul.11];6(2):PA1-PA3. Available from: http://iabcr.org/index.php/iabcr/article/view/587